InMed Pharmaceuticals (INM) EPS (Basic) (2021 - 2026)
InMed Pharmaceuticals (INM) posted quarterly EPS (Basic) of -$0.04 for Q1 2026, up 12.25% year-over-year from -$0.04 in Q1 2025, and up 91.59% quarter-over-quarter from -$0.51 in Q4 2025.
InMed Pharmaceuticals (INM) EPS (Basic) (2021 - 2026) Analysis & Trends
InMed Pharmaceuticals' EPS (Basic) history runs 6 years deep, the most recent figure standing at -$0.04 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 12.25% year-over-year to -$0.04; the TTM figure through Mar 2026 stood at -$1.29 (up 77.27% YoY), while the FY2025 annual figure was -$8.36, up 58.48% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.04, up from -$0.51 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.04 in Q1 2026, with the low at -$280.66 in Q2 2022.
- The 5-year median for EPS (Basic) is -$3.64 (2024), against an average of -$32.58.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) jumped 99.02% in 2023, then plunged 84.27% in 2024.
- InMed Pharmaceuticals' EPS (Basic) stood at -$18.24 in 2022, then jumped by 79.67% to -$3.71 in 2023, then rose by 1.71% to -$3.64 in 2024, then surged by 85.93% to -$0.51 in 2025, then soared by 91.59% to -$0.04 in 2026.
- Business Quant data shows INM's EPS (Basic) at -$0.04 in Q1 2026, -$0.51 in Q4 2025, and -$0.44 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.38 Mn | 1.14 Mn | - | -0.73 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.51 |
| Sep 30, 2025 | -0.44 |
| Jun 30, 2025 | -1.34 |
| Mar 31, 2025 | -0.05 |
| Dec 31, 2024 | -3.64 |
| Sep 30, 2024 | -2.71 |
| Jun 30, 2024 | -5.07 |
| Mar 31, 2024 | -3.58 |
| Dec 31, 2023 | -3.71 |
| Sep 30, 2023 | -15.24 |
| Jun 30, 2023 | -2.75 |
| Mar 31, 2023 | -12.00 |
| Dec 31, 2022 | -18.24 |
| Sep 30, 2022 | -81.10 |
| Jun 30, 2022 | -280.66 |
| Mar 31, 2022 | -122.80 |
| Dec 31, 2021 | -154.64 |
| Sep 30, 2021 | -123.33 |